FILING ANALYSIS · THURSDAY, NOVEMBER 12
ELITE PHARMACEUTICALS INC /NV/ ELTP — 8-K: Results of Operations and Financial Condition
positive
Elite Pharmaceuticals reported a 10.4% increase in revenues to $40.1 million and a 21% increase in income from operations to $9.9 million for the second quarter of fiscal year 2027, with net income attributable to common shareholders of $17.3 million. The company will host a conference call to discuss the results and provide a business update.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →